By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


F2G Ltd 

The Manchester Incubator Building
Grafton Street
Manchester    M139XX  United Kingdom
Phone: 44-0-161-606-7250 Fax: 44-0-161-606-7251



Company News
F2G Ltd and the University of Manchester Announce a New €6.1 Million Project to Develop New Antifungal Agents to Treat Resistant Fungal Infections 6/25/2013 10:14:17 AM
F2G Ltd Appoints Ian Nicholson as CEO 3/18/2013 9:05:45 AM
F2G Ltd Appoints John H. Rex to Board of Directors 2/19/2013 12:36:54 PM
F2G Ltd Raises $30 Million to Fund Pre-Clinical and Clinical Development of Novel Anti-Fungal Compounds 9/5/2012 6:40:47 AM
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors 9/13/2010 2:39:41 PM
F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors 2/24/2010 2:19:37 PM
F2G Ltd Initiates Phase I Clinical Trial for FG3622 7/7/2009 10:55:22 AM
F2G Ltd Announces Key Appointment and a Consolidation of the Management Team 2/12/2009 11:59:23 AM
F2G Ltd Announces Presentations at 48th Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) 10/24/2008 9:21:12 AM
F2G Ltd Completes £6.3 Million Financing Round to Fund Preclinical and Clinical Development 8/19/2008 9:13:40 AM